As already proposed by and confirmed in this study combined IL-4 and TNFα treatment exerts a synergistic effect on the increase of HLA class I antigen expression in RCC cells, which might enhance T cell-based anti-tumor responses [13]. Here, TNF is linked to renal cell carcinoma.